Artenga
About Artenga
Artenga is a company that focuses on the development of platform drug delivery technology in the medical sector. The company's main offerings include non-invasive, targeted drug delivery to the brain and immunotherapy, which involves activating the body's natural defenses against cancer. Artenga primarily serves the healthcare industry, particularly in areas related to serious diseases. It is based in Ontario, Canada.
Loading...
Loading...
Artenga Patents
Artenga has filed 3 patents.
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
1/7/2010 | 3/25/2014 | Medical ultrasonography, Fluid dynamics, Medical equipment, Ultrasound, Acoustics | Grant |
Application Date | 1/7/2010 |
|---|---|
Grant Date | 3/25/2014 |
Title | |
Related Topics | Medical ultrasonography, Fluid dynamics, Medical equipment, Ultrasound, Acoustics |
Status | Grant |
Artenga Frequently Asked Questions (FAQ)
Who are Artenga's competitors?
Competitors of Artenga include Keystone Dental, HistoSonics, ADVOS, Aethlon Medical, Promedtek and 7 more.
Loading...
Compare Artenga to Competitors
Emergent Respiratory Products, Inc., located in Irvine, CA, aims to develop, manufacture and market a medical device for delivering non-invasive ventilation therapy. Emergent's products can be utilized in a range of care settings, including emergency medical service (EMS) transport to the hospital and alternative site/home care settings.
Respiratory and infusion therapy for patients at home. Acquired by Lincare Holdings, Inc.
Aethlon Medical is the developer of the Hemopurifier - medical device that aims to treat infectious disease.
ADVOS, developed by ADVITOS, is a company focused on the healthcare sector, specifically in the field of intensive care treatment. The company's main offering is a certified innovative treatment for multi-organ failure in intensive care units, which simultaneously supports the kidney, liver, and lung functions, and also regulates the pH of the blood. The primary customers of ADVOS are likely to be healthcare providers in the intensive care industry. ADVOS was formerly known as Hepa Wash. It was founded in 2004 and is based in Munich, Germany.
HistoSonics develops a non-invasive platform and proprietary sonic beam therapy utilizing the science of histotripsy, a novel mechanism of action that uses focused ultrasound to mechanically destroy and liquefy unwanted tissue and tumors at sub-cellular levels. The company is focused on the development of its Edison platform, combining imaging with sensing technology to deliver personalized external beam treatments with precision and control, reducing the side effects of conventional therapies. The company was founded in 2009 and is based in Minneapolis, Minnesota.
Femeda is a UK based company focused on development of medical devices to treat incontinence and aims to offer solutions to conditions that can be accessed without visiting a healthcare professional.
Loading...